Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes - Concepedia

Concepedia

Publication | Closed Access

Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes

133

Citations

12

References

2018

Year

Brittany L. Murphy, Courtney N. Day, Tanya L. Hoskin, Elizabeth B. Habermann, Judy C. Boughey

Annals of Surgical Oncology

Breast OncologyMedicineNeoadjuvant Chemotherapy UseBreast CancerExcellent RespondersCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1